RENAL SALT-WASTING SYNDROME

This adverse event was reported 392 times

These drugs are most commonly taken by patients reporting RENAL SALT-WASTING SYNDROME:

# Drug Count
0 CISPLATIN 161
1 ETOPOSIDE 136
2 CARBOPLATIN 92
3 TACROLIMUS 27
4 TACROLIMUS EXTENDED-RELEASE CAPSULES 26
5 TACROLIMUS OINTMENT 0.1% 26
6 PREDNISOLONE 22
7 PREDNISOLONE ORAL 22
8 PREDNISOLONE ORAL SOLUTION 22
9 FLUOROURACIL 19
See all common drugs associated with RENAL SALT-WASTING SYNDROME

RENAL SALT-WASTING SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ADEFOVIR DIPIVOXIL 3 0.0024
1 CISPLATIN 161 0.0020
2 ETOPOSIDE 136 0.0019
3 CALCIUM POLYCARBOPHIL 3 0.0010
4 FERRIC CARBOXYMALTOSE 4 0.0008
5 BLEOMYCIN SULFATE 8 0.0008
6 CARBOPLATIN 92 0.0007
7 MANNITOL 3 0.0006
8 HALOPERIDOL DECANOATE 1 0.0006
9 MITOTANE 1 0.0005
See all drugs enriched for association with RENAL SALT-WASTING SYNDROME

RENAL SALT-WASTING SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 136 0.0018
1 Platinum-based Drug [EPC] 255 0.0009
2 Osmotic Diuretic [EPC] 3 0.0006
3 Actinomycin [EPC] 1 0.0005
4 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 3 0.0003
5 Lipid-based Polyene Antifungal [EPC] 3 0.0002
6 Antiseptic [EPC] 1 0.0002
7 Oxazolidinone Antibacterial [EPC] 6 0.0002
8 Phenothiazine [EPC] 5 0.0002
9 Nucleoside Metabolic Inhibitor [EPC] 33 0.0001
See all drug classes enriched for association with RENAL SALT-WASTING SYNDROME